Sales rise 11.90% to Rs 103.80 crore
Net profit of RPG Life Sciences rose 8.67% to Rs 7.52 crore in the quarter ended March 2022 as against Rs 6.92 crore during the previous quarter ended March 2021. Sales rose 11.90% to Rs 103.80 crore in the quarter ended March 2022 as against Rs 92.76 crore during the previous quarter ended March 2021.For the full year,net profit rose 28.70% to Rs 51.48 crore in the year ended March 2022 as against Rs 40.00 crore during the previous year ended March 2021. Sales rose 13.11% to Rs 440.16 crore in the year ended March 2022 as against Rs 389.14 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales103.8092.76 12 440.16389.14 13 OPM %13.0213.65 -19.6217.97 - PBDT14.7112.87 14 88.8370.05 27 PBT10.938.95 22 73.1753.58 37 NP7.526.92 9 51.4840.00 29
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
